View Article

  • Review on Oral Fast Dissolving Film Technology: Materials, Methods

  • 1Pharmaceutical Quality Assurance, Institute of Pharmacy and Research, Badnera-Amravati
    2 Pharmaceutical Chemistry, Institute of Pharmacy and Research, Badnera-Amravati
    3Pharmaceutical Chemistry, Institute of Pharmacy and Research, Badnera- Amravati

Abstract

Oral films represent a novel and patient-friendly drug delivery system designed to overcome limitations associated with conventional oral dosage forms, particularly in paediatric, geriatric, and dysphagic patients. These thin polymeric films rapidly hydrate upon contact with saliva, leading to quick disintegration and drug release without the need for water, thereby enhancing patient compliance and providing a faster onset of action. ODFs are formulated using hydrophilic film-forming polymers combined with plasticizers, sweetening agents, saliva-stimulating agents, surfactants, flavors, and colouring agents to achieve optimal mechanical strength, palatability, and performance. Ideal APIs for ODFs are potent, low-dose drugs with stability in aqueous environments. Various manufacturing techniques, such as solvent casting, semi-solid casting, hot-melt extrusion, and solid dispersion extrusion, are employed to produce uniform films. Evaluation of ODFs involves assessment of physical properties, disintegration and dissolution behaviour, mechanical strength, surface pH, drug content uniformity, and weight variation. Due to their ease of administration, rapid disintegration, and improved patient acceptability, ODFs have significant potential in modern pharmaceutical therapy.

Keywords

Oral dissolving films, Methods, Oral drug delivery system, film forming polymers, manufacturing techniques

Introduction

× Popup Image

Oral route of medicine administration is a most favored route due to its ease of administration, non-invasiveness, rigidity, patient compliance and adequacy. Regarding oral route of  medicine administration, numerous backups have continuously been presented by using recent  new technologies for pediatrics,  elders,  squeamish andnon-compliance cases. Bioadhesive mucosal lozenge forms including  tenacious tablets, gels and patches are  issues of technological development. Among  colorful lozenge forms, the use of polymeric  flicks for delivering  drug into buccal  depression has developed great  eventuality in recent area. Orally disintegrating flicks( ODFs), when placed on  lingo,  incontinently hydrates by soaking  slaver following decomposition and/ or dissolution releasing active pharmaceutical agent from the lozenge form. ODFs are kind of phrasings which are generally prepared using hydrophilic polymers enabling rapid-fire dissolution upon contact with slaver. Oral disintegrating tablets (ODTs) and oral disintegrating flicks( ODFs) are the typical  exemplifications of orally disintegrating  medicine delivery systems. These systems were developed in late 1970 to serve as an  volition to conventional lozenge forms, for case, fast disintegrating tablets and capsules for  elders and pediatric cases having difficulty in swallowing conventional lozenge forms. A typical ODF is  generally equal to the size of a postage stamp [1]  In  request place, the  preface of ODT was  explosively associated with comforting of cases about the applicable administration by giving instruction like ‘‘ do not chew/ do not swallow’’ still, in  malignancy of these instructions, incidents regarding biting  and swallowing were  frequently reported.[2]

1.1 Special features of Dissolving film [3]

  • Thin elegant film
  • Rapid drug release
  • Fast disintegration and dissolution

Advantages of oral film [4]

  • No need of water for administration
  • Convenient for pediatric, geriatric and dysphasic patients having difficulty in swallowing.
  • Rapid disintegrating and dissolution in the oral cavity due to larger surface area of films.
  • Rapid onset of action
  • Reduce dose, enhances the efficacy and safety profile of the drug with reduced side effects
  • Ease of administration to mentally ill, disabled , uncooperative patients and the patients who are on reduced liquid intake plans

Ideal properties of film forming polymers [5]

  • The polymers should be inert, nontoxic and non-irritant.
  • The polymer should have a better mouth feel property and good shelf-life.
  • The polymer should exhibit good spread ability and wetting property.
  • The polymers need to possess sufficient tensile, shear and peel strengths.
  • The polymer should be economical and readily available.

2. Formulation of dissolving film

  • Active pharmaceutical ingredient
  • Film forming polymers
  • Plasticizers
  • Sweetening agent
  • Saliva stimulating agent
  • Surfactants
  • Flavouring agent
  • Colouring agent

Active pharmaceutical agents: The active substance is may be from any class of pharmaceutically active substances that can be administered orally or through the buccal mucosa respectively. According to literature, API can be added from 5%-25% w/w of total weight of polymer. For the effective formulation, dose of drug should be in mgs (less than 20 mg/day). The drugs which are potent, show high first pass metabolism and patient non- compliant are best candidates for fast dissolving buccal films. Researchers have shown interest in development of fast dissolving films for drugs like: Pediatrics (antitussive, expectorants, antiasthamatics), Geriatrics (antiepileptic, expectorants), Gastrointestinal diseases, Nausea (e.g. due to cytostatic therapy), Pain (e.g. migraine), CNS (e.g. antiparkinsonism therapy).

Among which favored active agents include chlorpheniramine maleate, brompheniramine maleate, dexchloropheniramine, triprolidine hydrochloride, acrivastine, azatadine maleate, loratidine, phenylephrine hydrochloride, dextromethorphan hydrochloride, ketoprofen, sumatriptan succinate, zolmitriptan, loperamide, famotidine, nicotine, caffeine, diphenhydramine hydrochloride, and pseudophedrine hydrochloride, and their amounts per strip can be well known in the art.

Polymers A variety of polymers are available for medication of fast dissolving buccal  flicks. The polymers can be used alone or in combination to  gain the asked  film  parcels. The film  attained should be tough enough so that there will not be any damage while handling or during transportation. The robustness of the strip depends on the type of polymer and the  quantum in the expression. The  colourful polymers to make fast dissolving  flicks include cellulose or cellulosederivatives, pullulan, Gelatin, hydroxypropyl methyl cellulose,hydroxyethylcellolose,hydroxypropyl cellulose, polyvinylpyrrolidone, carboxymethylcellulose, polyvinylalchohal, sodium alginate, xanthine goo, tragacanth goo, guar goo, acacia goo, methylmethacrylate copolymer and hypromellose are most generally used for medication of fast dissolving  flicks. Modified beans are also used for medication. Due to low cost of this excipient it's used in combination of pullulan to  drop the overall cost of the product. Pullulan is a natural polymer  attained from nonanimal origin and does n't bear chemical  revision. About 50 to 80 percent w of pullulan can be replaced by  bounce in the  product of fast dissolving  flicks without loss of  needed  parcels of Pullulan. Combination of microcrystalline cellulose and maltodextrin has also been used to formulate fast dissolving  flicks. Kulkarni et al., 2010 explored different polymers for use in  expression of oral fast dissolving strips. Different polymers viz., HPMC E15, HPMC K4M, HPMC E5, PVP, PVA, gelatin, eudragit RL100 and pullalan were used to formulate  presto dissolving buccal  flicks; by solvent casting  system. Results  verified that pullalan is stylish polymer for oral fast dissolving strips [6]

Plasticizers: Plasticizer 7- 8 is a vital  component of the fast dissolving buccal  flicks  expression. The mechanical  parcels  similar as tensile strength and  extension to the  flicks can be  bettered by the addition of the plasticizer. Variations in their  attention affect these  parcels. The selection of the plasticizer will depend upon its  comity with the polymer and also the type of solvent employed in its casting. Plasticizers include glycerine, sorbitol, propylene glycol, polyethylene glycol, triacetin, di- butylpthalate, triethyl citrate, acetyl triethyl citrate and other citrate esters. generally the plasticizers are used in the  attention of 0- 20 w/ w of the dry polymer weight [7]. unhappy use of the plasticizer may lead to film cracking,  unyoking,  shelling of the strip and it may also affect the  immersion rate of the  medicine.

 Surfactants: Surfactants are used as solubilizing or wetting or dispersing agents so that the film gets dissolved within seconds and release active agent  incontinently. Surfactants also ameliorate the solubility of  inadequately answerable  medicines in fast dissolving buccal  flicks. Some of the generally used are polaxamer 407, sodium lauryl sulfate, benzalkonium chloride, benzthonium chloride, tweens and spans etc [8]

Sweetening agents: Sweeteners have come the important part of pharmaceutical products intended to be disintegrated or dissolved in the oral  depression. The classical source of sweetener is sucrose, dextrose, fructose, glucose, liquid glucose. The  agreeableness of fructose is perceived  fleetly in the mouth as compared to sucrose and dextrose. Fructose is sweeter than sorbitol and mannitol and  therefore used extensively as a sweetener. Polyhydric alcohols  similar as sorbitol, mannitol can be used in combination as they  also  give good mouth ‐  sense and cooling sensation. Polyhydric alcohols are less carcinogenic and don't have bitter after taste which is a vital aspect in formulating oral medications. The artificial sweeteners have gained generation of the artificial sweeteners followed by acesulfame ‐ K, sucralose, alitame and neotame which fall under the alternate generation artificial sweeteners. Acesulfame ‐ K and sucralose have further than 200 and 600 time agreeableness. Neotame and alitame have  further than 2000 and 8000 time  enhancing power as compared to sucrose. Rebiana which is a herbal sweetener, deduced from factory Stevia rebaudiana( South American factory) has  further than 200 ‐ 300 time  agreeableness [9]

Saliva Stimulating Agents: The purpose of using slaver stimulating agents is to increase the rate of  product of  slaver that would  prop  in the  briskly decomposition of the  rapid-fire dissolving strip  phrasings. Generally acids which are used in the medication of food can be  employed as salivary  instigations. Citric acid, malic acid, lactic acid, ascorbic acid and tartaric acid 10 are the many  exemplifications of salivary  instigations, citric acid being the most  favored amongst them.

Flavoring agents: seasoning agents can be  named from the synthetic flavor canvases, oleo resins, excerpt  deduced from  colorful  corridor of the  shops like leaves, fruits and flowers. Flavors can be used alone or in the combination. Any flavor can be added  similar as essential canvases  or water answerable excerpts of menthol,  violent mints  similar as peppermint, sweetmint, spearmint, wintergreen, cinnamon, clove, sour fruit flavor  similar as bomb, orange or sweet confectionery flavors 11 similar as vanillin, chocolate, or fruit  substance like apple,  jeer, cherry, pineapple. The  quantum of flavor  demanded to mask the taste depends on the flavor type and its strength.

Coloring agents: A full range of colours is available including FD & C colors, EU colours, natural colouring more fashionability in pharmaceutical medications. Saccharin, cyclamate and aspartame are the firstColoring agents A full range of colours is available including FD & C colors, EU colours, natural colouring agents, and natral juice concentrates,  colors  similar as titanium oxide, silicon dioxide and zinc dioxide and custom pantone- matched colours. These all coloring agents should n't exceed  attention  situations of 1 w/ w. these agents are incorporated when some of the  expression  constituents or  medicines are present in  undoable or  suspense form.

2.1 The ideal chracteristics of drug to be selected

  • The drug should have pleasant taste.
  • The therapeutic dose of the drug should not be greater than 40 mg.
  • The drug should have small molecular size and stability in water as well as in saliva.

Methods of preparation of Films

There are some methods in which oral dissolving films can be prepared, each of the methods are described below

  1. Preparation of film using, solvent casting method
  2. Semisolid casting
  3. Hot melt extrusion
  4. Solid dispersion extrusion
  5. Rolling method
  1. Solvent Casting Method It's one of the generally used  styles for the  expression of film. It's prepared using water-answerable polymers, excipients and  medicine. Due to the  operation of high shear, force a homogenous admixture is formed( Figure 1). The  result  attained is poured into antipode spread with coating  cutter to  gain  invariant consistence [12]

Figure 1: Solvent casting method

  1. Semi Solid Casting Method In this method, water-soluble polymeric film is prepared then the polymeric solution is added to acid insoluble polymeric solution .The sufficient quantity of plasticizers is added to obtain gel, the gel is casted into plate by required thickness. The acid insoluble polymer and water soluble polymeric solution should be in the ratio1:4 13-16

 

  1.  Hot Melt Extrusion: Hot melt extrusion is a technique in which a admixture containing medicine, polymer and excipients is extruded under high temperature to form a homogenous mass, which is then glided to form smooth films. This is a solvent free process; still, the processing of thermolabile substances is a major debit of this process due to the use of high temperature during extrusion

Fig No. 2 Hot melt extrusion

  1. Semi Solid Casting Method: This system is rather  espoused when acid  undoable polymers are to be used in the medication of the  flicks. Acid undoable polymers used to prepare  flicks include cellulose acetate phthalate, cellulose acetate butyrate. Acid undoable polymer and film forming polymer should be used in the  rate of 1:4.

 

Fig No. 3 Semi solid casting method

  1. Solid Dispersion Extrusion Method: Solid dispersion of domperidone using beta-cyclodextrin, PEG400 and HPMC E15 was successfully prepared and films were casted using solid dispersion extrusion method. [17-18]

Fig No. 4.Solid Dispersion Extrusion Method

  • Evaluation of formulation
  1. Physical characteristics observation [19-20] Characteristics similar as homogecity, colour,  translucency, inflexibility, fineness and  face of the oral  flicks were  estimated by visual  examination.
  2. Thickness [21,22] The thickness of film is measured by micrometer screw gauge at different strategic locales. This is essential to ascertain uniformity in the thickness of the film as this is directly related to the delicacy of cure  in the film.
  3. Folding endurance [23] Folding endurance is determined by repeated folding of the film at the same place until the film breaks. The number of times the film is folded without breaking is reckoned  as the folding abidance value.
  4. In vitro disintegration studies [24] The disintegration time limit of 30 seconds or lower for orally disintegrating tablets described in CDER guidance can be applied to orodispersible films. Although, no sanictioned guidance is available for oral fast disintegrating films/strips, this may be used as a qualitative guideline for quality control test or at development stage. Typical decomposition time for flicks is 5–30 seconds. Decomposition  time gives an suggestion about the decomposition  characteristics and dissolution characteristics of the film. The film as per the confines (2 x 2 cm) required for cure  delivery was placed in a petridish containing 10 ml phosphate buffer (pH 6.8). Time needed for the film to break was noted as in vitro decomposition time. Petri dish was shaken with hands giving pulls. This test was performed on three flicks of each formulation and mean±S.D calculated.
  5. Dissolution test [25 ]Dissolution testing can be performed using the standard handbasket or paddle apparatus described in any of the pharmacopoeia. The dissolution medium will basically be named as per the sink conditions and loftiest cure of the API. Numerous times the dissolution test can be delicate due to tendency of the film to float onto the dissolution medium when the paddle apparatus is employed. still, formerly film gets wet it goes into the result. Both apparatus are suitable to use and have substantiation  to be use. The in vitro dissolution test was carried out in a paddle dissolution apparatus. Samples of Ondansetron Hydrochloride films were exactly counted. In this case, the film of 2×2 cm (4 cm2) was dissolved in 500 ml phosphate buffer (pH 6.8) at 50 rpm. The temperature of the dissolution media was maintained at 37±0.5 °C. During the study, 5 ml of aliquots were withdrawn at 1, 2, 3, 4, 5, 6, 7 and 8 min and were replaced by fresh buffer. The aliquots were filtered using wattman sludge paper and used for UV determination at 249 nm.
  6. Surface pH  A film with too important acidic or introductory pH affects the area of operation and causes damages to oral mucosal membrane leading to patient discomfort. It is likely that the chemical nature of the medicine and the excipients influences the pH of the set flicks. In this, the face pH of the set flicks was measured after allowing it to wet by keeping it in contact with distilled water for a short period at room temperature. It was measured by touching to bulb of pH cadence.
  7. Drug content and content uniformity [26] Content uniformity is determined by estimating the API content in individual film. Limit of content uniformity is 85–115%. The film was cut in 2×2 cm in size dissolved in 50 ml of phosphate buffer pH 6.8, sonicated for 15 minutes ,also sludge using wattman sludge paper. This result was used for UV analysis and also attention of medicine is determined for checking medicine uniformity.
  8. Weight variations [27-28] For weight variation, individual films are counted and the average weights are calculated. also the average weight of the flicks is abated from the individual weight of the flicks. A large variation in weight indicates the inefficiency of the system employed and is likely to have non-uniform medicine content. This test was carried out for three films of size 2×2 cm in size cut from single film.
  9. Tensile strength [29] Oral film should retain moderate tensile strength, high chance extension (E), low Young’s Modulus, and high percent of medicine release. Tensile strength is the outside stress applied to a point at which the film instance breaks. For the tensile strength, Brookfield’s TexturePro CT V1.4 CT3 Texture Analyzer was used.

Formula given below is used for determination of Tensile strength

Tensile strength= Load at failure × 100

Strip thickness × Strip width Type equation here.

  1. Percent Elongation [30-31] When stress is applied, a film sample stretches and this is appertained to as strain. Strain is the distortion of film divided by original dimension of the sample. Generally, elongation of strip increases as the plasticizer content increases.

% Elongation = Increase in length of strip × 100 Initial length of Strip

CONCLUSION

In conclusion, oral films represent an innovative and patient-centric drug delivery system that addresses many limitations of conventional oral dosage forms. These films rapidly disintegrate in the oral cavity without the need for water, offering enhanced patient compliance, comfort, and convenience, especially for paediatric, geriatric, dysphagia, and non-cooperative patients. ODFs improve therapeutic performance by enabling rapid onset of action, bypassing first-pass metabolism, and enhancing bioavailability, while also providing precise dosing and ease of administration. Although challenges such as limited drug loading, moisture sensitivity, and special packaging requirements persist, ongoing research and formulation advancements continue to expand the practical utility of ODFs in pharmaceutical therapy. Overall, orally disintegrating films are a promising and adaptable platform that can potentially replace or supplement traditional dosage forms and improve the quality of drug delivery across diverse patient populations.

    REFERENCES

  1. Arya A, Chandra A, Sharma V, Pathak K. Fast dissolving oral films: an innovative drug delivery system and dosage form. Int J ChemTech Res. 2010;2:576–583.
  2. Bhyan B, Jangra S, Kaur M, Singh H. Orally fast dissolving films: innovations in formulation and technology. Int J Pharm Sci Rev Res. 2011;9(2):9–15.
  3. Bala R, Pawar P, Khanna S, Arora S. Orally dissolving strips: a new approach to oral drug delivery system. Int J Pharm Investig. 2013;3(2):67.
  4. Jangra PK, Sharma S, Bala R. Fast dissolving oral films: novel way for oral drug delivery. Int J Uni Pharma Bio Sci. 2014;3(1):6–27.
  5. Nagar P, Singh K, Chauhan I, Verma M, Yasir M, Khan A, et al. Orally disintegrating tablets: formulation, preparation techniques and evaluation. J Appl Pharm Sci. 2011;1:35–45.
  6. Kulkarni AS, Deokule HA, Mane MS, Ghadge DM. Exploration of different polymers for use in the formulation of oral fast dissolving strips. J Curr Pharm Res. 2010;2(1):33–35.
  7. Sakellariou P, Rowe RC. Interactions in cellulose derivative films for oral drug delivery. Prog Polym Sci. 1995;20(5):889–942.
  8. Mahajan A, Chhabra N, Aggarwal G. Formulation and characterization of fast dissolving buccal films: a review. Der Pharm Lett. 2011;3(1):152–165.
  9. Raymond CR, Sheskey PJ, Owen SC. Handbook of Pharmaceutical Excipients. 5th ed. London: Pharmaceutical Press; 2006.
  10. Rowe RC, Sheskey PJ, Weller PJ, editors. Handbook of Pharmaceutical Excipients. 6th ed. London: Pharmaceutical Press; 2006. p. 94–96.
  11. Prakash I, DuBois GE, Clos JF, Wilkens KL, Fosdick LE. Development of rebiana, a natural, non-caloric sweetener. Food Chem Toxicol. 2008;46(7 Suppl 1):S75–S82.
  12. Siddiqui MN, Garg G, Sharma PK. A short review on a novel approach in oral fast dissolving drug delivery system and their patents. Adv Biol Res. 2011;5(6):291–303.
  13. Barnhart SD. Thin film oral dosage forms in modified release. Drug Dev Technol. 2007;1:34–35.
  14. Nishimura M, Matsuura K, Tsukioka T, Yamashita H, Inagaki N, Sugiyama T, et al. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. Int J Pharm. 2009;368(1–2):98–102.
  15. Mahajan A, Chhabra N, Aggarwal G. Formulation and characterization of fast dissolving buccal films: a review. Der Pharm Lett. 2011;3(1):152–165.
  16. Zayed GM, Abd-El Rasoul S, Ibrahim MA, Saddik MS, Alshora DH. In vitro and in vivo characterization of domperidone-loaded fast dissolving buccal films. Saudi Pharm J. 2020;28(3):266–273.
  17. Patil H, Tiwari RV, Repka MA. Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS PharmSciTech. 2016;17(1):20–42.
  18. Thakur RR, Rathore DS, Narwal S. Orally disintegrating preparations: recent advancement in formulation and technology. J Drug Deliv Ther. 2012;2(3):87–96.
  19. Goel H, Rai P, Rana V, Tiwary AK. Orally disintegrating systems: innovations in formulation and technology. Recent Pat Drug Deliv Formul. 2008;2(3):258–274.
  20. Prabhu SC, Parsekar SD, Shetty A, Monteiro SS, Azharuddin M, Shabaraya AR. A review on fast dissolving sublingual films for systemic drug delivery. Int J Pharm Chem Sci. 2014;3(2):501–511.
  21. Daud AS, Sapkal NP, Bonde MN. Development of Zingiber officinale in oral dissolving films: effect of polymers on in vitro, in vivo parameters and clinical efficacy. Asian J Pharm. 2011;5(3).
  22. Nair AB, Kumria R, Harsha S, Attimarad M, Al-Dhubiab BE, Alhaider IA. In vitro techniques to evaluate buccal films. J Control Release. 2013;166(1):10–21.
  23. Sievens-Figueroa L, Bhakay A, Jerez-Rozo JI, Pandya N, Romañach RJ, Michniak-Kohn B, et al. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS class II drug nanoparticles for pharmaceutical applications. Int J Pharm. 2012;423(2):496–508.
  24. Liew KB, Tan YTF, Peh KK. Characterization of oral disintegrating film containing donepezil for Alzheimer disease. AAPS PharmSciTech. 2012;13(1):134–142.
  25. Ahmed MG, Charyulu RN, Harish NM, Prabhu P. Formulation and in vitro evaluation of chitosan films containing tetracycline for the treatment of periodontitis. Asian J Pharm. 2009;3(2).
  26. Saini S, Nanda A, Dhari J. Formulation, development and evaluation of oral fast dissolving anti-allergic film of levocetirizine dihydrochloride. J Pharm Sci Res. 2011;3(7):1322.
  27. El-Setouhy DA, El-Malak NSA. Formulation of a novel tianeptine sodium orodispersible film. AAPS PharmSciTech. 2010;11(3):1018–1025.
  28. Lakshmi PK, Sreekanth J, Sridharan A. Formulation development of fast releasing oral thin films of levocetirizine dihydrochloride with Eudragit® EPO and optimization through Taguchi orthogonal experimental design. Asian J Pharm. 2011;5(2).
  29. Arya A, Chandra A, Sharma V, Pathak K. Fast dissolving oral films: an innovative drug delivery system and dosage form. Int J ChemTech Res. 2010;2(1):576–583.
  30. Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139(2):94–107.
  31. Gauri S, Kumar G. Fast dissolving drug delivery and its technologies. Pharma Innov. 2012;1(2 Part A):34

Reference

  1. Arya A, Chandra A, Sharma V, Pathak K. Fast dissolving oral films: an innovative drug delivery system and dosage form. Int J ChemTech Res. 2010;2:576–583.
  2. Bhyan B, Jangra S, Kaur M, Singh H. Orally fast dissolving films: innovations in formulation and technology. Int J Pharm Sci Rev Res. 2011;9(2):9–15.
  3. Bala R, Pawar P, Khanna S, Arora S. Orally dissolving strips: a new approach to oral drug delivery system. Int J Pharm Investig. 2013;3(2):67.
  4. Jangra PK, Sharma S, Bala R. Fast dissolving oral films: novel way for oral drug delivery. Int J Uni Pharma Bio Sci. 2014;3(1):6–27.
  5. Nagar P, Singh K, Chauhan I, Verma M, Yasir M, Khan A, et al. Orally disintegrating tablets: formulation, preparation techniques and evaluation. J Appl Pharm Sci. 2011;1:35–45.
  6. Kulkarni AS, Deokule HA, Mane MS, Ghadge DM. Exploration of different polymers for use in the formulation of oral fast dissolving strips. J Curr Pharm Res. 2010;2(1):33–35.
  7. Sakellariou P, Rowe RC. Interactions in cellulose derivative films for oral drug delivery. Prog Polym Sci. 1995;20(5):889–942.
  8. Mahajan A, Chhabra N, Aggarwal G. Formulation and characterization of fast dissolving buccal films: a review. Der Pharm Lett. 2011;3(1):152–165.
  9. Raymond CR, Sheskey PJ, Owen SC. Handbook of Pharmaceutical Excipients. 5th ed. London: Pharmaceutical Press; 2006.
  10. Rowe RC, Sheskey PJ, Weller PJ, editors. Handbook of Pharmaceutical Excipients. 6th ed. London: Pharmaceutical Press; 2006. p. 94–96.
  11. Prakash I, DuBois GE, Clos JF, Wilkens KL, Fosdick LE. Development of rebiana, a natural, non-caloric sweetener. Food Chem Toxicol. 2008;46(7 Suppl 1):S75–S82.
  12. Siddiqui MN, Garg G, Sharma PK. A short review on a novel approach in oral fast dissolving drug delivery system and their patents. Adv Biol Res. 2011;5(6):291–303.
  13. Barnhart SD. Thin film oral dosage forms in modified release. Drug Dev Technol. 2007;1:34–35.
  14. Nishimura M, Matsuura K, Tsukioka T, Yamashita H, Inagaki N, Sugiyama T, et al. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. Int J Pharm. 2009;368(1–2):98–102.
  15. Mahajan A, Chhabra N, Aggarwal G. Formulation and characterization of fast dissolving buccal films: a review. Der Pharm Lett. 2011;3(1):152–165.
  16. Zayed GM, Abd-El Rasoul S, Ibrahim MA, Saddik MS, Alshora DH. In vitro and in vivo characterization of domperidone-loaded fast dissolving buccal films. Saudi Pharm J. 2020;28(3):266–273.
  17. Patil H, Tiwari RV, Repka MA. Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS PharmSciTech. 2016;17(1):20–42.
  18. Thakur RR, Rathore DS, Narwal S. Orally disintegrating preparations: recent advancement in formulation and technology. J Drug Deliv Ther. 2012;2(3):87–96.
  19. Goel H, Rai P, Rana V, Tiwary AK. Orally disintegrating systems: innovations in formulation and technology. Recent Pat Drug Deliv Formul. 2008;2(3):258–274.
  20. Prabhu SC, Parsekar SD, Shetty A, Monteiro SS, Azharuddin M, Shabaraya AR. A review on fast dissolving sublingual films for systemic drug delivery. Int J Pharm Chem Sci. 2014;3(2):501–511.
  21. Daud AS, Sapkal NP, Bonde MN. Development of Zingiber officinale in oral dissolving films: effect of polymers on in vitro, in vivo parameters and clinical efficacy. Asian J Pharm. 2011;5(3).
  22. Nair AB, Kumria R, Harsha S, Attimarad M, Al-Dhubiab BE, Alhaider IA. In vitro techniques to evaluate buccal films. J Control Release. 2013;166(1):10–21.
  23. Sievens-Figueroa L, Bhakay A, Jerez-Rozo JI, Pandya N, Romañach RJ, Michniak-Kohn B, et al. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS class II drug nanoparticles for pharmaceutical applications. Int J Pharm. 2012;423(2):496–508.
  24. Liew KB, Tan YTF, Peh KK. Characterization of oral disintegrating film containing donepezil for Alzheimer disease. AAPS PharmSciTech. 2012;13(1):134–142.
  25. Ahmed MG, Charyulu RN, Harish NM, Prabhu P. Formulation and in vitro evaluation of chitosan films containing tetracycline for the treatment of periodontitis. Asian J Pharm. 2009;3(2).
  26. Saini S, Nanda A, Dhari J. Formulation, development and evaluation of oral fast dissolving anti-allergic film of levocetirizine dihydrochloride. J Pharm Sci Res. 2011;3(7):1322.
  27. El-Setouhy DA, El-Malak NSA. Formulation of a novel tianeptine sodium orodispersible film. AAPS PharmSciTech. 2010;11(3):1018–1025.
  28. Lakshmi PK, Sreekanth J, Sridharan A. Formulation development of fast releasing oral thin films of levocetirizine dihydrochloride with Eudragit® EPO and optimization through Taguchi orthogonal experimental design. Asian J Pharm. 2011;5(2).
  29. Arya A, Chandra A, Sharma V, Pathak K. Fast dissolving oral films: an innovative drug delivery system and dosage form. Int J ChemTech Res. 2010;2(1):576–583.
  30. Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139(2):94–107.
  31. Gauri S, Kumar G. Fast dissolving drug delivery and its technologies. Pharma Innov. 2012;1(2 Part A):34

Photo
Radhika D. Holkar
Corresponding author

Pharmaceutical Quality Assurance, Institute of Pharmacy and Research Badnera Amravati

Photo
P.G. Patil
Co-author

Pharmaceutical Quality Assurance, Institute of Pharmacy and Research, Badnera-Amravati

Photo
S. J. Dighade
Co-author

Pharmaceutical Chemistry, Institute of Pharmacy and Research, Badnera- Amravati

Radhika D. Holkar*, P.G. Patil, S. J. Dighade, Establishment of Animal Research Facilities in Review on Oral Fast Dissolving Film Technology: Materials, Methods, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 6, 3740-3751. https://doi.org/10.5281/zenodo.20705329

More related articles
Impurity Profiling in Pharmaceuticals: An Overview...
Kanmani S, Varshya M, Yashica C, Swetha P...
Awareness Regarding the Role of Diet in the Preven...
Md Sayeed Anwar, Abel B., Asad Raza, Khushi Gupta, Supriya Mehta,...
Hepatotoxicity: Comprehensive Review...
Mahesh Manke , Padmaja Giram, Smita Shirale, Madhuri Shinde, Saba...
Comprehensive Review on Cinnamon Essential Oil-Loaded Microcapsules and Their An...
Abhisekh Koiri, Dr. Nidhi Srivastava, Lokendra Kumar Pandey...
Formulation and Evaluation of Poly-Hebal shampoo....
Krushna Zagade, DR. Ramesh Ingole, Shyam Aawchar, Swapnali Kale, Aarati Jamkar...
Related Articles
Novel Liquid-Assisted Grinding (LAG) Synthesis and Characterization of Schiff Ba...
Shraddha Chitale, Bhagyshree Jagtap, Sakshi Walunj, Ganesh Vitukade...
The Next Frontier Mucoadhesive and Mucus-Penetrating Nanoparticles: Overcoming t...
Pallavi Bilwe, Ayush Papadkar, Gayatri Badode, Samiksha Sonwal...
Microsphere-Based Drug Delivery Systems: An Overview...
Pathlavath Nithin, Dr. K. Anie Vijetha, Dr. M. Sunitha Reddy ...
Impurity Profiling in Pharmaceuticals: An Overview...
Kanmani S, Varshya M, Yashica C, Swetha P...
More related articles
Impurity Profiling in Pharmaceuticals: An Overview...
Kanmani S, Varshya M, Yashica C, Swetha P...
Awareness Regarding the Role of Diet in the Prevention of Iron and Vitamin D Def...
Md Sayeed Anwar, Abel B., Asad Raza, Khushi Gupta, Supriya Mehta, Himanshu Roy, Sushil Raj, Md Musab...
Hepatotoxicity: Comprehensive Review...
Mahesh Manke , Padmaja Giram, Smita Shirale, Madhuri Shinde, Saba Shaikh...
Impurity Profiling in Pharmaceuticals: An Overview...
Kanmani S, Varshya M, Yashica C, Swetha P...
Awareness Regarding the Role of Diet in the Prevention of Iron and Vitamin D Def...
Md Sayeed Anwar, Abel B., Asad Raza, Khushi Gupta, Supriya Mehta, Himanshu Roy, Sushil Raj, Md Musab...
Hepatotoxicity: Comprehensive Review...
Mahesh Manke , Padmaja Giram, Smita Shirale, Madhuri Shinde, Saba Shaikh...